Skip to main content

2 Result(s)

within M A Bensmaïne Remove this filter

and

  1. Article

    Open Access

    Factors predicting efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU) ± folinic acid in a compassionate-use cohort of 481 5-FU-resistant advanced colorectal cancer patients

    A statistical analysis was performed on the patient data collected from two compassionate-use programmes using oxaliplatin (Eloxatin®) + 5-fluorouracil (5-FU) ± folinic acid (FA), to identify predictive factor...

    M A Bensmaïne, M Marty, A de Gramont, S Brienza, F Lévi… in British Journal of Cancer (2001)

    Download PDF (300 KB)

  2. No Access

    Article

    Antitumoral activity of oxaliplatin/cisplatin-based combination therapy in cisplatin-refractory germ cell cancer patients

    Purpose: Only 20–30% of patient with advanced germ cell tumors, relapsing after standard first-line therapy, are curable with current second-line cisplatin-based regimens. New salvage combinations incorporating ...

    P. Soulié, C. Garrino, M. A. Bensmaïne… in Journal of Cancer Research and Clinical On… (1999)